User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Cvs Group Plc LSE:CVSG London Ordinary Share GB00B2863827 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  20.00 0.87% 2,320.00 2,310.00 2,315.00 2,345.00 2,270.00 2,345.00 321,905 16:35:27
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Retailers 427.8 9.9 8.1 286.4 1,641

Cvs Share Discussion Threads

Showing 551 to 573 of 675 messages
Chat Pages: 27  26  25  24  23  22  21  20  19  18  17  16  Older
DateSubjectAuthorDiscuss
12/5/2019
08:28
Can you confirm the names in all positions so we know for sure who you refer to? Have you brought this forward to the FCA? -------- To make matters even more incredible CVS’s biggest shareholder Invesco Perpetual and ex-employer to CVS’s Chairman, both directors are budies from PWC audit days) somehow had the timely and opportunistic knack to dump 35 million pounds worth of shares in CVS, co-incidentally seen recent resignation of their current and last company secretaries and head of legal services
j0sekl
10/5/2019
06:54
Why is the City still smarting over CVS Vets and Dignity Funerals? CVS have made great stock, in the past, of bench marking against sister company Dignity Funerals. Then in late 2016 Dignity was on the skids, with questionable practices and pricing and a UK Government investigation by the CMA into the market.The writing was on the wall at Dignity Funeral, it’s shares crashed catastrophically and are now worth 25% of its original share price high. The joint (CVS/Dignity) executives and other directors, seeing the ensuing blood bath and contagion spreading seemingly dumped their shares in CVS vets netting themselves personally millions of pounds. To make matters even more incredible CVS’s biggest shareholder Invesco Perpetual and ex-employer to CVS’s Chairman, both directors are budies from PWC audit days) somehow had the timely and opportunistic knack to dump 35 million pounds worth of shares in CVS, with no questions asked from regulators!CVS Shares have gone down by 2/3rds For shareholders like me who invested in CVS pre their collapse in share price, we are unhappy and asking many difficult questions, which CVS won’t answer! Indeed, I’ve got the needle on CVS and asking all sorts of questions of the senior executives, which has co-incidentally seen recent resignation of their current and last company secretaries and head of legal services (who partly carry the can!) Draw your own conclusions! I've been writing to CVS and asking the dfficult questions and would like to share my further and quite staggering findings into CVS
gilessaint
03/5/2019
15:02
Just bought into this at 660p - seems to be of good value. Fingers crosses.
btfd497
01/4/2019
20:24
5% increase in share price from 2pm onwards (9am New York time). 2+2=?
grim
01/4/2019
20:24
5% increase in share price from 2pm onwards (9am New York time). 2+2=?
grim
29/3/2019
16:16
The rise is a mirror of the size of the previous drop which was way bigger. If they can convert margin improvements, stop splashing cash and begin growing earnings with their decent presence this might move back into the growth premium price range it used to enjoy.. maybe
j0sekl
29/3/2019
13:31
CVS Group PLC (CVSG:LSE): Last: 615.50, up 98.5 (+19.05%), High: 621.00, Low: 542.50, Volume: 1.11m BE The trading update with the interims reads better than expected, with a pick-up in LFL sales, improvement in gross margin and reduction in vacancy rate. This does not remove the issues, but certainly eases any concerns regarding short term issues and the balance sheet. LFL sales in practices +3.2% in H1, with Jan/Feb +c5% helped by price increases and milder weather. We are nudging up our PBT forecast by 3%-5% to reflect the recent improvements. The shares continue to look exceptional value on 8x EV/Ebitda to June 2020E given that recent industry acquisitions for similar businesses are closer to 15x. CVS is an obvious target for the industry consolidators. Shares trading on a PE of 10.7x and 8.1x EV/Ebitda to Jun 2020 12:05 pm BE That's Charles Hall at Peel Hunt. BE "an obvious target for the industry consolidators" .... like? BE I thought CVS itself was the consolidator. 12:06 pm BE And that the consolidation model with vets had all sorts of problems and dis-synergies, as we've banged on about here for what feels like decades. BE Anyway. 12:07 pm https://ftalphaville.ft.com/marketslive/2019-03-29/
edmondj
29/3/2019
13:02
I can't see anything in the results which justifies a +18% share price rise. What am I missing ?
ramridge
29/3/2019
10:35
Not sure I'm right but things look to be improving and it could easily be prey to someone while it's sub 1000p.
its the oxman
29/3/2019
08:50
I have to say I called that one wrong! lol You could be right, but wait until the next update to really see if things are on the mend.
bulltradept
29/3/2019
08:29
Guess it's relief that things are on the mend at least. Still issues but worst could now be over.
its the oxman
29/3/2019
07:36
Mmmmm result as expected unfortunately.
bulltradept
23/3/2019
18:15
I always take Glassdoor reviews with a pinch of salt. They tend to be the spurned workers who have an axe to grind which does not offer a balanced picture. There are some specific fundamentals that need to be demonstrated by the firm, internal management. Externalities like US data points will prob result in my increasing in stake if negative sentiment dislocates potential growth. But the growth here is all down to execution.. and that so be a critical watch point.
j0sekl
14/3/2019
13:35
Sold a few and made a bit back. Mars are a very different and mature business in this marketplace. You can’t benchmark CVS as a Mars they are way off and my hope is for a takeover for my remainder. May bail before financial results hit as all the predictions for this firm look very gloomy. The US market is very different to the UK the PE space is crowded and the panic buying PFM shares by directors to give faith to investors should send out alarm bells. But will bump the price up prior to the results.
mccookie
01/3/2019
10:24
Why up? Acquisition continues in this hot space, JAB’s Acquire USA Compassion-First Pet Hospitals, which operates 41 veterinary hospitals and emergency clinics in the US, values the company at $1.2bn. And recently seems Goldman Sach increasing stakes in the company. The market cap of around 350million pounds seems undervalued if benchmarking to other recent deals.. Just look at MARS...
compoundinge
01/3/2019
10:24
Why up? Acquisition continues in this hot space, JAB’s Acquire USA Compassion-First Pet Hospitals, which operates 41 veterinary hospitals and emergency clinics in the US, values the company at $1.2bn. And recently seems Goldman Sach increasing stakes in the company. The market cap of around 350million pounds seems undervalued if benchmarking to other recent deals.. Just look at MARS...
compoundinge
28/2/2019
21:10
Dont try and catch a falling scalpel blade.
arcticblast01
25/2/2019
12:43
Looking at Glassdoor reviews of how CVS management are running things at the moment gives a good indicator of employee engagement. Have to say does not make good reading... clearly retaining staff in particular vets is key to growth against competitors. Many negative comments about senior management. I think other PE ran vets are more attractive at the moment. I don’t see Amazon entering the Vet marketplace- more likely to take CVS is Mars/pedigree who are already significant having taken a number of vet companies and have the scale and background already to do so having ran multiple vets in the US.. that said the business needs to be well run and an attractive proposition which I cannot see at the moment or any noise from CVS to attract investors to believe otherwise.
mccookie
17/2/2019
10:27
Dignity is a different situation at the moment because there's disruption from online competitors. I think Amazon went in. This is not the case with the vetinary industry but CVS need to have their portal set-up and strong on advertising. They do need some data gathering for market intelligence to be strategic about where they buy. I am looking for them to become so well run that if Amazon did want to enter they buy up CVS instead of compete.
j0sekl
17/2/2019
04:53
This is a moment to see CVS's management quality as they face increased labour costs and there are now more PE-backed competitors in the market. I think it's an advantage they hold the biggest market share but I will not give them the chance of another slip-up. I am a late investor that came in predicated on their continual growth and margin conversion. So what am I looking for, 1. Whether they understand not overpaying for M&A 2. How they'll focus on financial strength as well as growth 3. Demonstrate they can outshine some respectable competitors. These have always been the data points but now is decision time. I want to see them set decent targets and not overpromise, which is the curse of growth companies.
j0sekl
05/2/2019
13:40
That’s what I thought at the time . I still think long term these will be ok.
kemorkid
05/2/2019
02:05
On 4th December Kemorkid, you stated it was a good entry point!CVS shares have just further crashed by another 1/3 leaving your credibility shot and anyone who took your suggestion nursing very heavy losses!
gilessaint
31/1/2019
21:31
I agree winky
kemorkid
Chat Pages: 27  26  25  24  23  22  21  20  19  18  17  16  Older
ADVFN Advertorial
Your Recent History
LSE
CVSG
Cvs
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210509 14:48:50